SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-220756
Filing Date
2012-05-09
Accepted
2012-05-09 10:53:06
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d348120d10q.htm 10-Q 365859
2 FIRST RIGHT TO NEGOTIATE AND AMENDMENT AGREEMENT d348120dex101.htm EX-10.1 50004
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d348120dex311.htm EX-31.1 9941
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER d348120dex312.htm EX-31.2 9853
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER d348120dex321.htm EX-32.1 4778
  Complete submission text file 0001193125-12-220756.txt   1597289

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT agenus-20120331.xml EX-101.INS 132297
7 XBRL TAXONOMY EXTENSION SCHEMA agenus-20120331.xsd EX-101.SCH 10458
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agenus-20120331_cal.xml EX-101.CAL 31632
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agenus-20120331_def.xml EX-101.DEF 26799
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE agenus-20120331_lab.xml EX-101.LAB 108726
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agenus-20120331_pre.xml EX-101.PRE 75789
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 12824284
SIC: 2836 Biological Products, (No Diagnostic Substances)